• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受异烟肼预防治疗的人类免疫缺陷病毒感染者中的活动性结核病

Active tuberculosis in individuals infected with human immunodeficiency virus after isoniazid prophylaxis.

作者信息

Fitzgerald D W, Morse M M, Pape J W, Johnson W D

机构信息

Groupe Haitien d'Etude du Sarcome de Kaposi et des Infections Opportunistes, Port au Prince, Haiti.

出版信息

Clin Infect Dis. 2000 Dec;31(6):1495-7. doi: 10.1086/317485.

DOI:10.1086/317485
PMID:11096020
Abstract

A review was conducted in Haiti to determine the timing and outcome of active tuberculosis (TB) in human immunodeficiency virus (HIV)-positive patients who had previously received isoniazid (INH) prophylaxis. Of 1005 HIV-seropositive patients who completed INH prophylaxis, 14 (1.4%) subsequently had active TB diagnosed. The median interval between discontinuation of INH prophylaxis and TB diagnosis was 8 months for 6 patients receiving 6 months of INH, 22 months for 5 patients receiving 12-24 months of INH, and 40 months for 3 patients receiving 24-36 months of INH (P = .026). There is a postprophylaxis effect on INH that is dependent upon the duration of therapy.

摘要

在海地进行了一项回顾性研究,以确定曾接受异烟肼(INH)预防性治疗的人类免疫缺陷病毒(HIV)阳性患者发生活动性结核病(TB)的时间和结果。在1005例完成INH预防性治疗的HIV血清阳性患者中,有14例(1.4%)随后被诊断为活动性TB。接受6个月INH治疗的6例患者,停止INH预防性治疗至TB诊断的中位间隔时间为8个月;接受12 - 24个月INH治疗的5例患者为22个月;接受24 - 36个月INH治疗的3例患者为40个月(P = 0.026)。INH预防性治疗后存在一种效应,该效应取决于治疗持续时间。

相似文献

1
Active tuberculosis in individuals infected with human immunodeficiency virus after isoniazid prophylaxis.接受异烟肼预防治疗的人类免疫缺陷病毒感染者中的活动性结核病
Clin Infect Dis. 2000 Dec;31(6):1495-7. doi: 10.1086/317485.
2
Isoniazid preventive therapy in human immunodeficiency virus-infected persons. Long-term effect on development of tuberculosis and survival.人类免疫缺陷病毒感染者的异烟肼预防性治疗。对结核病发生和生存的长期影响。
Arch Intern Med. 1997;157(15):1729-34.
3
Risk factors for development of tuberculosis after isoniazid chemoprophylaxis in human immunodeficiency virus-infected patients.人类免疫缺陷病毒感染患者接受异烟肼化学预防后发生结核病的危险因素。
Clin Infect Dis. 2002 Feb 1;34(3):386-9. doi: 10.1086/324746. Epub 2001 Dec 19.
4
Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease.异烟肼化学预防对HIV相关分枝杆菌病的影响。
Arch Intern Med. 1996 Apr 22;156(8):889-94.
5
A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS.对结核高危的无反应能力及感染人类免疫缺陷病毒者使用异烟肼的对照试验。艾滋病临床研究特里·贝恩社区项目。
N Engl J Med. 1997 Jul 31;337(5):315-20. doi: 10.1056/NEJM199707313370505.
6
Reduction of clinical tuberculosis in HIV-infected males with isoniazid prophylaxis.通过异烟肼预防减少HIV感染男性的临床结核病。
East Mediterr Health J. 2002 Nov;8(6):754-7.
7
Prospective randomized control trial of isoniazid chemoprophylaxis during renal replacement therapy.肾替代治疗期间异烟肼化学预防的前瞻性随机对照试验
Transpl Infect Dis. 2005 Sep-Dec;7(3-4):99-108. doi: 10.1111/j.1399-3062.2005.00103.x.
8
[Primary chemoprevention of tuberculosis in HIV-infected patients in non-industrialized countries].[非工业化国家中HIV感染患者结核病的初级化学预防]
Sante. 1997 Mar-Apr;7(2):89-94.
9
Effect of isoniazid prophylaxis on incidence of active tuberculosis among Thai HIV-infected individuals.异烟肼预防性治疗对泰国HIV感染者活动性结核病发病率的影响。
J Med Assoc Thai. 1996 May;79(5):285-7.
10
Missed opportunities for prevention of tuberculosis among persons with HIV infection--selected locations, United States, 1996-1997.1996 - 1997年美国部分地区艾滋病毒感染者中结核病预防的错失机会
MMWR Morb Mortal Wkly Rep. 2000 Aug 4;49(30):685-7.

引用本文的文献

1
Development of Hyphenated Techniques and Network Identification Approaches for Biotransformational Evaluation of Promising Antitubercular N-pyrrolyl hydrazide-hydrazone in Isolated Rat Hepatocytes.联用技术及网络识别方法用于在离体大鼠肝细胞中对有前景的抗结核N-吡咯基酰肼腙进行生物转化评估的研究进展
Chromatographia. 2023;86(6):497-505. doi: 10.1007/s10337-023-04260-5. Epub 2023 May 4.
2
Assessment of isoniazid preventive therapy in the reduction of tuberculosis among ART patients in Arba Minch Hospital, Ethiopia.埃塞俄比亚阿尔巴明奇医院抗逆转录病毒治疗患者中异烟肼预防性治疗对结核病减少效果的评估。
Ther Clin Risk Manag. 2017 Mar 24;13:361-366. doi: 10.2147/TCRM.S127765. eCollection 2017.
3
Use of isoniazid preventive therapy for tuberculosis prophylaxis among people living with HIV/AIDS: a review of the literature.
在艾滋病毒/艾滋病感染者中使用异烟肼预防性治疗预防结核病:文献综述
J Acquir Immune Defic Syndr. 2015 Apr 15;68 Suppl 3(Suppl 3):S297-305. doi: 10.1097/QAI.0000000000000497.
4
Microscopic observation drug susceptibility assay for tuberculosis screening before isoniazid preventive therapy in HIV-infected persons.结核分枝杆菌药物敏感性检测在 HIV 感染者异烟肼预防性治疗前的筛查中的应用
Clin Infect Dis. 2010 Apr 1;50(7):988-96. doi: 10.1086/651081.